Detalles de la búsqueda
1.
Clinical impact of gender and age at onset on disease trajectory in primary progressive multiple sclerosis patients.
Mult Scler
; 30(3): 336-344, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38247138
2.
Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in Argentina.
Neurol Sci
; 45(2): 379-389, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38159147
3.
Neuromyelitis Optica Spectrum Disorder in Latin America: State-of-the-Art and Current Challenges.
J Integr Neurosci
; 23(4): 74, 2024 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38682226
4.
Frequency of NMOSD misdiagnosis in a cohort from Latin America: Impact and evaluation of different contributors.
Mult Scler
; 29(2): 277-286, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36453614
5.
Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting.
Mult Scler
; 29(10): 1240-1249, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37491849
6.
Neuromyelitis optica spectrum disorders with and without associated autoimmune diseases.
Neurol Sci
; 44(5): 1731-1737, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36645533
7.
Argentinean consensus recommendations for the use of telemedicine in clinical practice in adult people with multiple sclerosis.
Neurol Sci
; 44(2): 667-676, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36319902
8.
Disability outcomes in NMOSD and MOGAD patients: data from a nationwide registry in Argentina.
Neurol Sci
; 44(1): 281-286, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36166174
9.
Chiasmatic lesions on conventional magnetic resonance imaging during the first event of optic neuritis in patients with neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein-associated disease in a Latin American cohort.
Eur J Neurol
; 29(3): 802-809, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34799965
10.
Brain and spinal MRI features distinguishing MS from different AQP4 antibody serostatus NMOSD at disease onset in a cohort of Latin American patients.
Mult Scler
; 26(8): 945-954, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31124748
11.
Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM).
Neurol Sci
; 41(11): 3329-3335, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32840711
12.
Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM).
Neurol Sci
; 41(6): 1513-1519, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31960250
13.
Correction to: Argentinean consensus recommendations for the use of telemedicine in clinical practice in adult people with multiple sclerosis.
Neurol Sci
; 44(3): 1135, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36348171
14.
Short-segment transverse myelitis lesions in a cohort of Latin American patients with neuromyelitis optica spectrum disorders.
Spinal Cord
; 56(10): 949-954, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29789706
15.
Correction to: Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM).
Neurol Sci
; 42(12): 5441, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34557969
16.
Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina.
Clin Neuropharmacol
; 2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38776535
17.
Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings.
J Neurol
; 2024 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38630312
18.
Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registry.
J Neurol Sci
; 461: 123052, 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38797140
19.
Barriers to access and unmet needs to neuromyelitis optica spectrum disorders care in an Argentinean cohort.
Mult Scler Relat Disord
; 70: 104485, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36610362
20.
Serological response to SARS-CoV-2 vaccines in patients with multiple sclerosis in Argentina.
Medicina (B Aires)
; 83(3): 358-365, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37379532